Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

about

Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C

P2860

Q41521289-7AD1B16D-660A-4A81-AF0B-BF4E319E9670

P2860

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

Item

http://www.wikidata.org/entity/Q38755098

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Daclatasvir and asunaprevir in ...... retrospective study in Japan.

@en

type

Item

label

Daclatasvir and asunaprevir in ...... retrospective study in Japan.

@en

prefLabel

Daclatasvir and asunaprevir in ...... retrospective study in Japan.

@en

P1476

Daclatasvir and asunaprevir in ...... retrospective study in Japan.

@en

P2093

Atsushi Hiraoka

http://www.w3.org/2001/XMLSchema#string

Atsushi Nagasaka

http://www.w3.org/2001/XMLSchema#string

Etsuko Iio

http://www.w3.org/2001/XMLSchema#string

Goki Suda

http://www.w3.org/2001/XMLSchema#string

Hidenori Toyoda

http://www.w3.org/2001/XMLSchema#string

Hiroki Ikeda

http://www.w3.org/2001/XMLSchema#string

Kanji Kato

http://www.w3.org/2001/XMLSchema#string

Kazuaki Chayama

http://www.w3.org/2001/XMLSchema#string

Keiji Tsuji

http://www.w3.org/2001/XMLSchema#string

Keiko Arataki

http://www.w3.org/2001/XMLSchema#string

P2860

Global epidemiology and genotype distribution of the hepatitis C virus infection

Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis.

IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin.

A novel simple assay system to quantify the percent HCV-RNA levels of NS5A Y93H mutant strains and Y93 wild-type strains relative to the total HCV-RNA levels to determine the indication for antiviral therapy with NS5A inhibitors.

Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients.

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b

Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.

P31

scholarly article

P356

10.1007/S00535-017-1353-Y

http://www.w3.org/2001/XMLSchema#string

P50

Naoya Sakamoto

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28560477

http://www.w3.org/2001/XMLSchema#string

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

about

P2860

P2860

Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698